Skip to main content
Caplight Logo









PsyLabs

PsyLabs

Private
Cape TownHealthcare & Life Scienceshttps://psylabs.life/

Last Round

Series A

Aug 15, 2025

Est. Valuation

$10M

Total Funding Raised

$9.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PsyLabs is a biotechnology company that specializes in the cultivation, extraction, and production of pharmaceutical-grade psychedelic active pharmaceutical ingredients (APIs) for medical and clinical research markets.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

psychedelic APIactive pharmaceutical ingredientAPIGMP-compliantclinical trial supplypsilocybinibogainepsychedelic medicinebotanical extractpsychedelic researchmescalineDMTdimethyltryptaminemental health therapeuticspsychedelic pharmabiotech supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PsyLabs Comparables

Compare PsyLabs with similar companies based on industry and business-model similarity.

PsyLabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Natural MedTech
89%
Psygen Industries Ltd.
83%
Eywa Biotech
81%

PsyLabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 15, 2025
StrategicApr 15, 2025
SeedDec 3, 2024

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2026

    Grew 25% QoQ, from 12 to 15 employees.

PsyLabs Filings

Explore SEC and related filing metadata, where available.

PsyLabs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PsyLabs's valuation, stock price, and market status.

Is PsyLabs a public or private company?

PsyLabs is a private company.

What is the current stock price of PsyLabs?

PsyLabs is a private company with no public stock price. No recent secondary market data is available.

How much is PsyLabs worth (valuation)?

PsyLabs's valuation is estimated at $10.0M based on funding round data.

Can I buy PsyLabs stock?

PsyLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PsyLabs's last funding round?

PsyLabs's most recent funding round was Series A on December 3, 2024.

Who are the main investors in PsyLabs?

Investor information for PsyLabs is not publicly disclosed.

Will PsyLabs IPO soon?

No public IPO plans have been announced for PsyLabs.

How can I track PsyLabs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PsyLabs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCape Town
Employee Range15
Year Founded2021
Last FundingAug 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?